目的:L-抗坏血酸(维生素C)是一种必需的水溶性维生素,在各种生理功能中起着重要作用,包括免疫健康。维生素C在胃肠道中的稳定性其生物利用度是有限的。本研究旨在研究与标准维生素C相比,脂质体形式的维生素C是否可以增加吸收。
方法:在随机分组中,双盲,安慰剂对照,跨界时尚,男性19例,女性8例(n=27;36.0±5.1岁,165.0±6.9cm,70.6±7.1kg)摄入单剂量安慰剂(PLA),500毫克维生素C(VITC),和500毫克脂质体维生素C(LV-VITC,LipoVantage®,Specnova,LLC,泰森角,VA,美国)。收集静脉血样0,0.5-,1-,1.5-,2-,3-,4-,6-,8-,12-,和摄入后24小时,并分析血浆和白细胞维生素C浓度。
结果:与安慰剂相比,VITC和LV-VITC在血浆和白细胞中显示出明显更大的Cmax和AUC0-24(p<0.001)。此外,LV-VITC具有显著较高的Cmax(血浆+27%,白细胞+20%,p<0.001)和AUC0-24(血浆+21%,白细胞+8%,与VITC相比,p<0.001)值。
结论:维生素C的脂质体制剂增加了血浆和白细胞的吸收。
背景:临床试验注册-印度(CTRI/2023/04/051789)。
OBJECTIVE: L-Ascorbic acid (vitamin C) is an essential water-soluble vitamin that plays an important role in various physiological functions, including immune health. The stability of vitamin C in the gastrointestinal tract its bioavailability is limited. This study aimed to investigate if a liposomal form of vitamin C can increase absorption compared to standard vitamin C.
METHODS: In a randomized, double-blind, placebo-controlled, crossover fashion, 19 males and 8 females (n = 27; 36.0 ± 5.1 years, 165.0 ± 6.9 cm, 70.6 ± 7.1 kg) ingested a single-dose of placebo (PLA), 500 mg vitamin C (VIT C), and 500 mg liposomal vitamin C (LV-VIT C, LipoVantage®, Specnova, LLC, Tyson Corner, VA, USA). Venous blood samples were collected 0, 0.5-, 1-, 1.5-, 2-, 3-, 4-, 6-, 8-, 12-, and 24-hours after ingestion and were analyzed for plasma and leukocyte vitamin C concentration.
RESULTS: VIT C and LV-VIT C demonstrated significantly greater Cmax and AUC0 - 24 in plasma and in leukocytes compared to placebo (p < 0.001). Additionally, LV-VIT C had significantly higher Cmax (plasma + 27%, leukocytes + 20%, p < 0.001) and AUC0 - 24 (plasma + 21%, leukocytes + 8%, p < 0.001) values as compared to VIT C.
CONCLUSIONS: Liposomal formulation of vitamin C increases absorption into plasma and leukocytes.
BACKGROUND: Clinical Trials Registry - India (CTRI/2023/04/051789).